Sponsor Pipeline

Electra Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05416307 Open-label Study of ELA026 in Participants With Secondary Hemophagocytic… Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Recruiting
Phase 1
NCT07465835 A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies… T Cell Malignancies Recruiting
Get alerts when Electra Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free